About the Company
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders, including psoriasis. vTv's development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease (COPD), renal disease, and primary mitochondrial myopathy.
Employees
25
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VTVT News
vTv Therapeutics, Inc. Class A
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet ...
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
HIGH POINT, N.C., March 13, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an oral adjunctive therapy to ...
VTv Therapeutics: Q4 Earnings Snapshot
HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Wednesday reported a loss of $3.5 million in its fourth quarter. The High Point, North Carolina-based company ...
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type ...
VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company’s lead drug ...
vTv Therapeutics Inc. Cl A
1 Day VTVT -2.83% DJIA 0.56% Russell 2K 0.24% Health Care/Life Sciences -1.10% ...
vTv Therapeutics Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
vTv Therapeutics Inc (VTVT)
On March 25, 2024, The Nasdaq Stock Market LLC (“Nasdaq”) notified vTv Therapeutics (NASDAQ:VTVT) that the Company had regained compliance with Nasdaq Listing Rule 5550(b)(2), ...
vTv Therapeutics Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
vTv Therapeutics Inc (VTVT)
Bullish doji Star 5H 68 Feb 16, 2024 02:00PM ...
Loading the latest forecasts...